Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes
Naveed, A
The cheapest number in the market (Trava, $147) comes from a provider that would not name its pharmacy
Metabolic dysfunction-associated steatohepatitis (MASH) is a chronic disease characterized by liver inflammation and fibrosis related to obesity or metabolic disorders
